相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis
Ahad Eshraghian et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
High Prevalence of Nonalcoholic Fatty Liver Disease in the Middle East: Lifestyle and Dietary Habits
Ahad Eshraghian
HEPATOLOGY (2017)
Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis
Yukiomi Nakade et al.
HEPATOLOGY RESEARCH (2017)
Inhibitory effects of vitamin E on osteocyte apoptosis and DNA oxidative damage in bone marrow hemopoietic cells at early stage of steroid-induced femoral head necrosis
Yan-Bo Jia et al.
MOLECULAR MEDICINE REPORTS (2017)
Farnesoid X Receptor an Emerging Target to Combat Obesity
C. Daniel De Magalhaes Filho et al.
DIGESTIVE DISEASES (2017)
Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density
Ahad Eshraghian
MINERVA ENDOCRINOLOGICA (2017)
Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
Fatemeh Mofidi et al.
BRITISH JOURNAL OF NUTRITION (2017)
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2017)
A Randomized Controlled Clinical Trial Investigating the Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Biomarkers of Oxidative Stress, Inflammation and Pregnancy Outcomes in Gestational Diabetes
Mehri Jamilian et al.
CANADIAN JOURNAL OF DIABETES (2017)
Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease
Daniel Steinacher et al.
DIGESTIVE DISEASES (2017)
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans
Stefano Ballestri et al.
ADVANCES IN THERAPY (2016)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
The rise, the fall and the renaissance of vitamin E
Angelo Azzi et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
Scott Friedman et al.
CONTEMPORARY CLINICAL TRIALS (2016)
Novel Pharmacotherapy Options for NASH
Vlad Ratziu
DIGESTIVE DISEASES AND SCIENCES (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Alexandra Montagner et al.
GUT (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation
Jia-Hung Ye et al.
SCIENTIFIC REPORTS (2016)
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
Eric Lefebvre et al.
PLOS ONE (2016)
Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial
An Tang et al.
DIABETES CARE (2015)
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2015)
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease
Paola Dongiovanni et al.
HEPATOLOGY (2015)
Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)
Rohit Loomba et al.
HEPATOLOGY (2015)
Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease
Sahar Mohamed El-Haggar et al.
HEPATOLOGY INTERNATIONAL (2015)
Statin use and non-alcoholic steatohepatitis in at risk individuals
Paola Dongiovanni et al.
JOURNAL OF HEPATOLOGY (2015)
PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
Sven Francque et al.
JOURNAL OF HEPATOLOGY (2015)
Current efforts and trends in the treatment of NASH
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Nonalcoholic fatty liver disease and statins
Konstantinos Tziomalos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification
Alastair D. Burt et al.
SEMINARS IN LIVER DISEASE (2015)
The Gut Microbiota and Nonalcoholic Fatty Liver Disease
Eamonn M. Quigley et al.
SEMINARS IN LIVER DISEASE (2015)
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease
Sanjaya K. Satapathy et al.
SEMINARS IN LIVER DISEASE (2015)
Genetic polymorphisms and oxidative stress in non-alcoholic steatohepatitis (NASH): A mini review
Claudia P. Oliveira et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
Tannaz Eslamparast et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model
Cindy Kunne et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
The Fatty Acid-Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
Rifaat Safadi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Liraglutide Enhances Insulin Sensitivity by Activating AMP-Activated Protein Kinase in Male Wistar Rats
Satoru Yamazaki et al.
ENDOCRINOLOGY (2014)
Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies
Tao Zeng et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Cardiovascular effects of statins, beyond lipid-lowering properties
Christos G. Mihos et al.
PHARMACOLOGICAL RESEARCH (2014)
Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
Juan Du et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Non-alcoholic fatty liver disease and thyroid dysfunction: A systematic review
Ahad Eshraghian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet
Masateru Ushio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review
Zun Xiang et al.
BMC GASTROENTEROLOGY (2013)
Peroxisome proliferator-activated receptor δ: a multifaceted metabolic player
Lazar A. Bojic et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
Bertrand Cariou et al.
DIABETES CARE (2013)
Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies
M. Ferwana et al.
DIABETIC MEDICINE (2013)
Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Maria Stepanova et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Bart Staels et al.
HEPATOLOGY (2013)
Rhabdomyolysis Developing Secondary to Atorvastatin Therapy in a Patient with Liver Cirrhosis
Ahad Eshraghian et al.
INTERNAL MEDICINE (2013)
Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis
Yusaku Shirai et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells
Eva Moran-Salvador et al.
JOURNAL OF HEPATOLOGY (2013)
NAFLD, NASH and liver cancer
Gregory A. Michelotti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis
Wei Wang et al.
PLOS ONE (2013)
Angiotensin II Facilitates Fibrogenic Effect of TGF-β1 through Enhancing the Down-Regulation of BAMBI Caused by LPS: A New Pro-Fibrotic Mechanism of Angiotensin II
Yu-Sheng Li et al.
PLOS ONE (2013)
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Yan-Yan Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
Takumi Hirata et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
Steatohepatitis in laboratory opossums exhibiting a high lipemic response to dietary cholesterol and fat
Jeannie Chan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet
Jamie E. Mells et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis
J. Massart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis
Roberto Fogari et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes
Guifen Qiang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Naga Chalasani et al.
GASTROENTEROLOGY (2012)
Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
Thuy-Anh Le et al.
HEPATOLOGY (2012)
Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
Claudia O. Zein et al.
HEPATOLOGY (2012)
Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
Georgios S. Papaetis et al.
CURRENT DRUG TARGETS (2011)
Pentoxifylline Improves Nonalcoholic Steatohepatitis: A Randomized Placebo-Controlled Trial
Claudia O. Zein et al.
HEPATOLOGY (2011)
Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Losartan in the Treatment of Nonalcoholic Steatohepatitis in Humans: A 12-Month Randomized, Prospective, Open-Label Trial
Dawn M. Torres et al.
HEPATOLOGY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Eric A. Klein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2011)
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies
Yoon Kong Loke et al.
BRITISH MEDICAL JOURNAL (2011)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
Sabrina Cipriani et al.
JOURNAL OF LIPID RESEARCH (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients
Adeline Bertola et al.
PLOS ONE (2010)
Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials
Markus Schuerks et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis A Randomized Placebo-controlled Trial
Austin Nelson et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
John Willy Haukeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease
C. Fernandez-Miranda et al.
DIGESTIVE AND LIVER DISEASE (2008)
Rosiglitazone for nonalcoholic steatohepatitis: One-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial
Vlad Ratziu et al.
GASTROENTEROLOGY (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
The effect of thiazolidinediones on BMD and osteoporosis
Allyson K. McDonough et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Long-term risk of cardiovascular events with rosiglitazone - A meta-analysis
Sonal Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis
Glen Lutchman et al.
HEPATOLOGY (2007)
Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus
M. Bajaj et al.
DIABETOLOGIA (2007)
Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance
Roger Gutierrez-Juarez et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis
Shiro Yokohama et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock
M Abdelrahman et al.
CARDIOVASCULAR RESEARCH (2005)
Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality
ER Miller et al.
ANNALS OF INTERNAL MEDICINE (2005)
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
S Yokohama et al.
HEPATOLOGY (2004)
Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet
SWP Koppe et al.
JOURNAL OF HEPATOLOGY (2004)
Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
E Akriviadis et al.
GASTROENTEROLOGY (2000)
Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X
B Idzior-Walus et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
